-+ 0.00%
-+ 0.00%
-+ 0.00%

Keurig Dr Pepper (KDP) Stock Looks Strong On Returns While Earnings Look Stretched

Simply Wall St·09/05/2026 02:19:19
Listen to the news

Keurig Dr Pepper stock has logged a solid 17.6% return over the past year, yet the broader valuation checks suggest the shares lean expensive rather than clearly cheap. For investors, the interest now is whether that recent run is already baking in much of the good news.

  • The 17.6% 1-year return points to steady investor demand that may already reflect a fair amount of optimism in the current share price.
  • The planned split into separate Beverage Co. and Global Coffee Co. businesses can support a cleaner focus on each segment, while execution risks around the separation and use of proceeds from asset sales may weigh on how investors price the stock.
  • With a low value score of 2 out of 6 checks, Keurig Dr Pepper does not screen as a clear bargain on the usual valuation yardsticks.

The key question for investors is whether Keurig Dr Pepper’s current valuation leaves enough room for further upside after this performance and the planned reshaping of the business.

Broaden your watchlist beyond Keurig Dr Pepper by reviewing hand picked consumer stocks that combine resilient demand with room for re rating in our 47 high quality undervalued stocks

Is Keurig Dr Pepper Getting Expensive on Earnings?

P/E is a useful check for Keurig Dr Pepper because earnings remain a key anchor for how investors look at established consumer brands. The stock currently trades on a P/E of about 33.0x, which is well above the Beverage industry average of 17.4x and also above the peer group average of 24.5x. That points to investors paying a higher price for each dollar of current earnings than is typical across similar beverage companies.

The tailored fair P/E ratio for Keurig Dr Pepper, which adjusts for factors such as its business mix, size and risk profile, sits at around 25.5x. This is meaningfully below the current 33.0x level, which indicates the shares trade at a sizeable premium even after accounting for those company specific factors. Despite the recent Chobani stake sale and debt reduction plans, the present P/E still values Keurig Dr Pepper at a rich level relative to what this model suggests.

On the P/E multiple, Keurig Dr Pepper stock appears overvalued compared with both its fair ratio and sector benchmarks.

NasdaqGS:KDP P/E Ratio as at Sep 2026
NasdaqGS:KDP P/E Ratio as at Sep 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Keurig Dr Pepper Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Keurig Dr Pepper pick up where this valuation puzzle leaves off. They spell out what growth, margin and earnings paths would need to occur for the stock to be worth materially more or less than today’s price. Each one presents a fair value as a thesis about Keurig Dr Pepper’s business that you can revisit over time on the company’s Community page.

You can be one of the first voices in the Simply Wall St community to set out a number driven narrative on Keurig Dr Pepper, including a view on whether the Chobani stake and facility sale ahead of the corporate split delivers the kind of earnings path that would back up today’s valuation. Share your thesis now and track how it holds up as new results and transaction updates arrive.

Do you think there's more to the story for Keurig Dr Pepper? Head over to our Community to see what others are saying!

The Bottom Line

For Keurig Dr Pepper, the current market multiple suggests the stock is priced for a relatively optimistic earnings path compared with sector peers. Broader valuation checks point to an overvalued profile, so the margin for error looks limited if the corporate split or operational plans do not go smoothly. The crux for investors now is whether earnings delivery and execution on the separation can support the existing premium or whether the P/E ratio drifts closer to sector norms over time.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.